Healius Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HLS.AX | ACL.AX | IDX.AX | SAB.F | DGX | GSS.AX | |
|---|---|---|---|---|---|---|
| Market cap | 359.46M | 596.86M | 646.50M | 6.13B | 28.22B | 17.49M |
| P/E (TTM) | — | 26.7 | 28.8 | 17.1 | 25.5 | — |
| Forward P/E | -145.6 | 15.3 | 13.2 | — | 21.3 | -1.7 |
| Price/book | 2.1 | 4.0 | 1.0 | 1.2 | 3.7 | 0.5 |
| Dividend yield | — | 4.10% | 5.45% | 5.54% | 1.35% | — |
| 1-year change | −43.02% | +21.46% | −32.87% | +4.41% | +38.60% | −74.96% |
| Today | +1.02% | +0.95% | +1.47% | +0.08% | +3.49% | 0.00% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All HLS.AX news ›Health Check: Despite a sickly Dr AI diagnosis, Healius flags higher earnings
"I'm going to deliver this to you gently, but you're the worst case of hypochondria I've ever seen." Pic: Getty Images Pathology chain Healius (ASX:HLS) has affirmed its current-year earnings expectations, despite the unhelpful tendency of…
Healius Limited (PHCRF) Shareholder/Analyst Call Transcript
Healius Limited (PHCRF) Shareholder/Analyst Call October 21, 2026 8:01 PM EDT Kathryn McKenziePaul Anderson - MD, CEO & DirectorGillian NairnSteven Rubic Good morning, everybody. My name is Kate McKenzie. And on behalf of the Board, I…
Can Healius (ASX:HLS) Lift Earnings Despite Pressure From AI Self-Diagnosis?
Management said many Australians now rely on AI-generated summaries without checking sources or clinical context, which raises the risk of misunderstanding, misdiagnosis or delayed care. Research the company commissioned found that nearly…
Healius vs Australian Clinical Labs: Which ASX pathology share wins?
Healius and Australian Clinical Labs are both top pathology providers, but one stands out for profits, dividends, and recent momentum. Healius is one of Australia's largest pathology service providers, operating under well-known brands…
Healius Confirms Sale of Agilex Biolabs to Novotech at AU$160 Million
Healius confirmed that it signed a binding agreement to sell its Agilex Biolabs business to a unit of Novotech Health Holdings for an enterprise value of AU$160 million. The company said the... Healthcare Facilities & Services Healius…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- fool.com.au1
- kalkinemedia.com1
- marketscreener.com1
- seekingalpha.com1
- stockhead.com.au1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.